Pricing Log in Create free account

Trevi Therapeutics, Inc. (TRVI) vs Zenas BioPharma, Inc. (ZBIO)

Trevi Therapeutics, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Trevi Therapeutics, Inc. and Zenas BioPharma, Inc. are of similar size ($1.7B and $1.7B). Across the 10 metrics below, Trevi Therapeutics, Inc. leads on 8 and Zenas BioPharma, Inc. on 2.

Valuation

Metric TRVI ZBIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 5.78 6.30 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (2.86%) (36.44%) (33.15%)
Free cash flow yield (2.84%) (14.51%) (25.50%)

Profitability

Metric TRVI ZBIO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (19.66%) (199.04%) (56.36%)
Return on assets (18.97%) (97.39%) (48.04%)
Return on invested capital (1,412.11%) 0.00% 0.00%

Growth

Metric TRVI ZBIO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 31.91% 29.04% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric TRVI ZBIO Biotechnology median
Debt to equity 0.00 1.57 0.00
Current ratio 37.28 9.93 4.72
Net debt to EBITDA 3.83 0.69 0.96

Dividend

Metric TRVI ZBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TRVI ZBIO Biotechnology median
Market cap 1.73b 1.66b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack